Accueil   Diary - News   All news VALBIOTIS confirms its interest in the study of the intestinal microbiota

VALBIOTIS confirms its interest in the study of the intestinal microbiota

  • VALBIOTIS develops leading expertise in this field of research
  • VALBIOTIS compiles a base of human data in the field of metabolic diseases, with high value potential
  • VALBIOTIS focuses on the French population’s understanding of the intestinal microbiota through an exclusive Opinéa survey

 

La Rochelle, 17 October 2018 (17:35 CEST) – VALBIOTIS (ALVAL/PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, confirms its interest in the study of the intestinal microbiota, a promising field of investigation on innovative solutions for metabolic diseases.

 

Read the press release